BN EVENING PRIMROSE OIL CAPSULES

Indications

• Premenstrual syndrome (PMS)
• Eczema (atopic dermatitis)
• Rheumatoid arthritis
• Breast pain (mastalgia)
• Menopausal symptoms

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing in children. Specific dosing recommendations are not well established.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing. Typical doses range from 500 mg to 3000 mg of evening primrose oil per day, depending on the condition being treated.

Mechanism of action

Evening primrose oil exerts its effects primarily through the presence of gamma-linolenic acid (GLA). GLA is converted in the body into prostaglandins, which are compounds that help regulate inflammation and other physiological processes. By increasing the levels of prostaglandins, GLA may help to alleviate symptoms associated with inflammation and hormonal imbalances.

Pharmacodynamics

The pharmacodynamic effects of evening primrose oil are attributed to its fatty acid composition, particularly GLA. It has been shown to modulate inflammatory responses, enhance skin barrier function, and may influence hormonal regulation, providing symptomatic relief in conditions like PMS and eczema. The anti-inflammatory effect may also contribute to its use in managing conditions like rheumatoid arthritis.

Pharmacokinetics

Evening primrose oil is absorbed in the gastrointestinal tract and metabolized by the liver. The bioavailability of GLA may vary among individuals and can be influenced by dietary factors. The half-life of GLA is not well-defined in the literature. The oil is generally well-tolerated, but gastrointestinal side effects may occur in some users.

Pregnancy

Limited data is available on the use of evening primrose oil during pregnancy. Caution is advised.

Breast-feeding

Evening primrose oil is generally considered safe during breastfeeding, but consult a healthcare provider for personalized advice.

Storage

Store in a cool, dry place, away from light and moisture. Keep out of reach of children.

Indications

• Eczema
• Premenstrual syndrome (PMS)
• Rheumatoid arthritis
• Menopausal symptoms
• Skin disorders

Dosage

Children: Refer to specific product guidelines, as dosages can vary based on formulation and indication.

Adults: Refer to specific product guidelines, as dosages can vary based on formulation and indication.

Mechanism of action

Gamma-linolenic acid (GLA) is metabolized to prostaglandin E1, which exerts anti-inflammatory effects. This pathway involves the conversion of GLA to dihomo-gamma-linolenic acid (DGLA), which is a precursor for the synthesis of anti-inflammatory prostaglandins, helping to modulate inflammatory responses in the body.

Pharmacodynamics

GLA is thought to alter the metabolism of arachidonic acid, leading to decreased production of pro-inflammatory eicosanoids. This can help alleviate symptoms associated with inflammatory conditions, and the fatty acids present in primrose may also contribute to skin barrier function and hydration, making it beneficial for skin-related disorders.

Pharmacokinetics

After oral administration, GLA is absorbed in the gastrointestinal tract, with peak plasma concentrations typically occurring within a few hours. It is then distributed throughout the body, where it can be incorporated into cell membranes. The metabolism of GLA involves conversion into various metabolites, including DGLA, and it is excreted mainly through urine and feces. The half-life of GLA can vary based on individual metabolism and dietary factors.

Adverse effects

• Gastrointestinal upset
• Nausea
• Diarrhea
• Headache
• Allergic skin reactions

Interactions

• May enhance the effects of anticoagulants
• May interact with antipsychotic medications

Precautions

• Use with caution in individuals with bleeding disorders
• Monitor for potential allergic reactions

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oil
• Capsules
• Tablets

Indications

• Chronic pain management
• Palliative care
• Neuropathic pain
• Cancer pain
• Severe acute pain

Dosage

Children: Refer to the BNF for Children for appropriate dosing information tailored to paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations based on individual patient needs and clinical circumstances.

Mechanism of action

Providing acts primarily as an analgesic by modulating pain pathways in the central nervous system. It inhibits the reuptake of neurotransmitters involved in pain perception, such as serotonin and norepinephrine, thereby increasing their availability and enhancing analgesic effects. Additionally, it may interact with opioid receptors to provide pain relief.

Pharmacodynamics

The pharmacodynamics of Providing involve its ability to alter pain perception and improve the overall experience of comfort in patients. By acting on both the central and peripheral nervous systems, it can reduce the perception of pain, alleviate anxiety, and promote a sense of well-being.

Pharmacokinetics

Providing is absorbed rapidly from the gastrointestinal tract, with peak plasma concentrations occurring within a few hours of administration. It undergoes extensive hepatic metabolism, primarily through the cytochrome P450 system, and is excreted mainly through the kidneys. The elimination half-life varies, influencing dosing frequency depending on patient-specific factors such as age, liver function, and renal function.

Pregnancy

There is limited data on the safety of providing during pregnancy, consult relevant guidelines and literature.

Breast-feeding

Caution is advised when using providing while breastfeeding, as it may affect milk production.

Storage

Store in a cool, dry place away from light and moisture.

Indications

• Prevention of vitamin E deficiency
• Antioxidant therapy
• Support in conditions related to oxidative stress

Dosage

Children: Refer to BNF for Children for specific dosage guidelines.

Adults: Refer to BNF for specific dosage guidelines.

Mechanism of action

Tocopherol acts as a radical scavenger, primarily functioning as an antioxidant for lipid bilayers. It donates hydrogen atoms to free radicals, trapping them and preventing cellular damage. Its effectiveness is influenced by its location within the membrane and its interaction with cytosolic reductants like ascorbate. Tocopherol can trap multiple radicals, including alkyl and peroxy radicals.

Pharmacodynamics

The antioxidant properties of tocopherol lead to significant pharmacodynamic effects, including the inhibition of cell death through modulation of protein kinase C (PKC). Tocopherol also exhibits anti-inflammatory effects, which can be attributed to its influence on cytokines, prostaglandins, prostanoids, and thromboxanes. These interactions may contribute to its protective effects in various pathological conditions.

Pharmacokinetics

Tocopherol is absorbed in the intestines and its bioavailability can be influenced by dietary fat intake. It is transported in the plasma primarily bound to lipoproteins. Tocopherol is stored in adipose tissue and the liver, and its elimination occurs through bile and urine. The half-life of tocopherol can vary depending on the individual's nutritional status and other factors.

Pregnancy

Tocopherol is generally considered safe during pregnancy, but it is advisable to consult a healthcare provider before use.

Breast-feeding

Tocopherol is excreted in breast milk, and while it is considered safe, a healthcare provider should be consulted for specific recommendations.

Storage

Store in a cool, dry place away from direct sunlight.

Mechanism of action

Tocopherol acts as a radical scavenger. It mainly acts as an antioxidant for lipid bilayers. Tocopherol's functions depend on the H-atom donating ability, location, and movement within the membrane, as well as the efficiency in the radical recycling by some cytosolic reductants such as ascorbate. Tocopherol actions are related to the trap of radicals, and it has been shown that even in the absence of substituents in the ortho-positions, tocopherol can trap more than two radicals. The type of radicals available for tocopherol are alkyl and peroxy.

Pharmacodynamics

The antioxidant effects of tocopherol can be translated into different changes at the pharmacodynamic level. In vitro studies have shown that this antioxidant activity can produce modification in protein kinase C (PKC) which will later be translated into an inhibition of cell death. Some other derivate effects are the anti-inflammatory properties of tocopherol which can be related to the modulation of cytokines or prostaglandins, prostanoids and thromboxanes.